Immunosuppression Induced by Glutamine Deprivation Occurs via Activating PD-L1 Transcription in Bladder Cancer
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Immunosuppression Induced by Glutamine Deprivation Occurs via Activating PD-L1 Transcription in Bladder Cancer
Authors
Keywords
-
Journal
Frontiers in Molecular Biosciences
Volume 8, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2021-11-05
DOI
10.3389/fmolb.2021.687305
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Targeting SLC1A5 blocks cell proliferation through inhibition of mTORC1 in arsenite-treated human uroepithelial cells
- (2021) Sihao Li et al. TOXICOLOGY LETTERS
- Metabolic regulation of EGFR effector and feedback signaling in pancreatic cancer cells requires K-Ras
- (2020) Szu-Wei Lee et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Restricting extracellular Ca2+ on gefitinib-resistant non-small cell lung cancer cells reverses altered epidermal growth factor-mediated Ca2+ response, which consequently enhances gefitinib sensitivity
- (2020) Mi Seong Kim et al. PLoS One
- Self-crosslinkable chitosan-hyaluronic acid dialdehyde nanoparticles for CD44-targeted siRNA delivery to treat bladder cancer
- (2020) Ye Liang et al. Bioactive Materials
- Glutamine and the Tumor Immune Microenvironment
- (2019) Izak Faiena et al. EUROPEAN UROLOGY
- EGFR-Pak Signaling Selectively Regulates Glutamine Deprivation-Induced Macropinocytosis
- (2019) Szu-Wei Lee et al. DEVELOPMENTAL CELL
- Glutamine Deprivation Induces PD-L1 Expression via Activation of EGFR/ERK/c-Jun Signaling in Renal Cancer
- (2019) Guofeng Ma et al. MOLECULAR CANCER RESEARCH
- Glutamine blockade induces divergent metabolic programs to overcome tumor immune evasion
- (2019) Robert D. Leone et al. SCIENCE
- Activation of RAW264.7 macrophages by active fraction of Albizia julibrissin saponin via Ca2+–ERK1/2–CREB–lncRNA pathways
- (2019) Chenying Wang et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Targeting tumor-intrinsic hexosamine biosynthesis sensitizes pancreatic cancer to anti-PD1 therapy
- (2019) Nikita S. Sharma et al. JOURNAL OF CLINICAL INVESTIGATION
- Glutamate production from ammonia via glutamate dehydrogenase 2 activity supports cancer cell proliferation under glutamine depletion
- (2018) Yukiko Takeuchi et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Epigenetic regulators of programmed death-ligand 1 expression in human cancers
- (2018) Sachin Kumar et al. Translational Research
- A Role for p53 in the Adaptation to Glutamine Starvation through the Expression of SLC1A3
- (2018) Mylène Tajan et al. Cell Metabolism
- Chemotherapeutic Treatments Increase PD-L1 Expression in Esophageal Squamous Cell Carcinoma through EGFR/ERK Activation
- (2018) Hoi Yan Ng et al. Translational Oncology
- The elevated glutaminolysis of bladder cancer and T cells in a simulated tumor microenvironment contributes to the up-regulation of PD-L1 expression by interferon-γ
- (2018) Liping Wang et al. OncoTargets and Therapy
- IKKβ activates p53 to promote cancer cell adaptation to glutamine deprivation
- (2018) Mari B. Ishak Gabra et al. Oncogenesis
- Cell-specific mechanisms of TMEM16A Ca2+-activated chloride channel in cancer
- (2017) Hui Wang et al. Molecular Cancer
- Radiation alters PD-L1/NKG2D ligand levels in lung cancer cells and leads to immune escape from NK cell cytotoxicity via IL-6-MEK/Erk signaling pathway
- (2017) Ming Jing Shen et al. Oncotarget
- ASCT2 (SLC1A5) is an EGFR-associated protein that can be co-targeted by cetuximab to sensitize cancer cells to ROS-induced apoptosis
- (2016) Haiquan Lu et al. CANCER LETTERS
- Differential Glutamate Metabolism in Proliferating and Quiescent Mammary Epithelial Cells
- (2016) Jonathan L. Coloff et al. Cell Metabolism
- Local checkpoint inhibition of CTLA-4 as a monotherapy or in combination with anti-PD1 prevents the growth of murine bladder cancer
- (2016) Luuk van Hooren et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Regional glutamine deficiency in tumours promotes dedifferentiation through inhibition of histone demethylation
- (2016) Min Pan et al. NATURE CELL BIOLOGY
- Molecular and Biochemical Aspects of the PD-1 Checkpoint Pathway
- (2016) Vassiliki A. Boussiotis NEW ENGLAND JOURNAL OF MEDICINE
- Tumor-associated mutant p53 promotes cancer cell survival upon glutamine deprivation through p21 induction
- (2016) T Q Tran et al. ONCOGENE
- Overexpression of JARID1B promotes differentiation via SHIP1/AKT signaling in human hypopharyngeal squamous cell carcinoma
- (2016) Jisheng Zhang et al. Cell Death & Disease
- RAS–Mitogen-Activated Protein Kinase Signal Is Required for Enhanced PD-L1 Expression in Human Lung Cancers
- (2016) Hidetoshi Sumimoto et al. PLoS One
- Regulation of PD-L1: a novel role of pro-survival signalling in cancer
- (2015) J. Chen et al. ANNALS OF ONCOLOGY
- Human Pancreatic Cancer Tumors Are Nutrient Poor and Tumor Cells Actively Scavenge Extracellular Protein
- (2015) J. J. Kamphorst et al. CANCER RESEARCH
- Induction of PD-L1 Expression by the EML4-ALK Oncoprotein and Downstream Signaling Pathways in Non-Small Cell Lung Cancer
- (2015) K. Ota et al. CLINICAL CANCER RESEARCH
- Anti-PD-1 and PD-L1 therapy for bladder cancer: what is on the horizon?
- (2015) Srinath Sundararajan et al. Future Oncology
- Upregulation of PD-L1 by EGFR Activation Mediates the Immune Escape in EGFR-Driven NSCLC: Implication for Optional Immune Targeted Therapy for NSCLC Patients with EGFR Mutation
- (2015) Nan Chen et al. Journal of Thoracic Oncology
- Metabolic pathways promoting cancer cell survival and growth
- (2015) Lindsey K. Boroughs et al. NATURE CELL BIOLOGY
- PD-L1 is a novel direct target of HIF-1α, and its blockade under hypoxia enhanced MDSC-mediated T cell activation
- (2014) Muhammad Zaeem Noman et al. JOURNAL OF EXPERIMENTAL MEDICINE
- The B55α Subunit of PP2A Drives a p53-Dependent Metabolic Adaptation to Glutamine Deprivation
- (2013) Michael A. Reid et al. MOLECULAR CELL
- Activation of the PD-1 Pathway Contributes to Immune Escape in EGFR-Driven Lung Tumors
- (2013) E. A. Akbay et al. Cancer Discovery
- The Activation of MAPK in Melanoma Cells Resistant to BRAF Inhibition Promotes PD-L1 Expression That Is Reversible by MEK and PI3K Inhibition
- (2012) X. Jiang et al. CLINICAL CANCER RESEARCH
- T-Cell Coregulatory Molecule Expression in Urothelial Cell Carcinoma: Clinicopathologic Correlations and Association with Survival
- (2008) S. A. Boorjian et al. CLINICAL CANCER RESEARCH
- Oncogenic kinase NPM/ALK induces through STAT3 expression of immunosuppressive protein CD274 (PD-L1, B7-H1)
- (2008) M. Marzec et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now